title: Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
authors.forename: M
authors.initials: M
authors.lastname: Itoh
authors.forename: K
authors.initials: K
authors.lastname: Uchimura
authors.forename: M
authors.initials: M
authors.lastname: Makino
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.forename: H
authors.initials: H
authors.lastname: Kakizawa
authors.forename: M
authors.initials: M
authors.lastname: Nagata
authors.forename: K
authors.initials: K
authors.lastname: Fujiwara
authors.forename: S
authors.initials: S
authors.lastname: Kato
authors.forename: Y
authors.initials: Y
authors.lastname: Itoh
authors.forename: A
authors.initials: A
authors.lastname: Nagasaka
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002032:Bulimia / Q000150:complications*; D002626:Chemistry, Pharmaceutical; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D004342:Drug Hypersensitivity; D005260:Female; D006681:HLA-D Antigens / Q000235:genetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects*; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000009:adverse effects
chemical_list: D001786:Blood Glucose; D006681:HLA-D Antigens; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D011994:Recombinant Proteins